Ipamorelin

Overview

Ipamorelin is a selective synthetic pentapeptide originally developed as a model compound for studying ghrelin receptor (GHS-R1a) pharmacology. Research has examined its role in GH release through GHSR-1a activation — a distinct pathway from GHRH receptor-mediated GH secretion — and it has been studied as an early example of high receptor selectivity within the GH secretagogue class. Preclinical characterization has reported Ipamorelin-associated GH secretion without significant effects on ACTH, prolactin, FSH, LH, TSH, or cortisol levels, a profile distinguishing it from earlier compounds in the GH secretagogue class. This selectivity profile has been examined in research studying receptor-targeted GH modulation independently of broader pituitary effects.

Beyond GH axis pharmacology, Ipamorelin has been studied in preclinical models of glucocorticoid-induced musculoskeletal changes, gastrointestinal motility, and metabolic signaling.

Chemical Profile

Research Findings

GH Axis and Receptor Selectivity Research

Ipamorelin has been studied as a selective GHS-R1a agonist for its effects on GH secretion through a defined receptor specificity profile. Preclinical pharmacological characterization reported dose-dependent GH release following Ipamorelin administration without significant effects on ACTH, prolactin, FSH, LH, TSH, or cortisol secretion — a selectivity profile examined in the context of differentiating GH secretagogue mechanisms. Research has used Ipamorelin as a model compound for studying receptor-binding precision, downstream cAMP and calcium signaling in somatotrophs, and GH pulse dynamics in experimental settings. Its distinct pathway from GHRH receptor signaling has also been examined in dual-pathway GH axis combination research alongside GHRH analogs.

Areas of Research

• GH axis pharmacology and ghrelin receptor (GHS-R1a) signaling studies
• Receptor selectivity modeling in GH secretagogue research
• Dual-pathway GH secretagogue combination research

Research Use Only: This product is sold exclusively for laboratory and scientific research. It is not approved for human or veterinary use or consumption.

Disclaimer: All products distributed by Resolve Peptides are supplied exclusively for controlled laboratory and scientific research. They are not drugs, supplements, or therapies, and have not been approved by the FDA or any regulatory authority for human or veterinary use. These products are not intended for human or veterinary administration. Regulatory status of research peptides is subject to change; it is the responsibility of the researcher to verify current applicable regulations in their jurisdiction prior to purchase. Any references to biological effects are based solely on experimental and preclinical data.